Respiratory Inhalers Market by Product Type, Age Group, Mode, Disease Indication, End-Use - Global Forecast 2025-2030- Product Image

Sale

Respiratory Inhalers Market by Product Type, Age Group, Mode, Disease Indication, End-Use - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 6012372

UP TO €685EUR$697USD£568GBP OFF until Dec 31^st 2024

The Respiratory Inhalers Market grew from USD 2.96 billion in 2023 to USD 3.24 billion in 2024. It is expected to continue growing at a CAGR of 9.74%, reaching USD 5.68 billion by 2030.

The respiratory inhalers market encompasses a range of devices designed to deliver medication directly to the lungs, playing a critical role in managing respiratory conditions like asthma, COPD, and other pulmonary diseases. The necessity of inhalers stems from the need for rapid, targeted drug delivery systems that enhance efficacy and minimize systemic side effects. They are crucial for both regular maintenance therapy and acute relief, making them indispensable in both healthcare settings and personal use. The market's end-use scope includes hospitals, clinics, and homecare, addressing diverse patient demographics globally. Growth is primarily influenced by rising respiratory disease prevalence, urban air pollution, and healthcare improvements in emerging regions. Technological advancements, such as smart inhaler devices integrating digital health solutions, open new avenues for monitoring patient adherence and disease management, presenting lucrative opportunities. However, challenges like stringent regulatory pathways, pricing pressures, and the complexity of formulation-device combinations can hinder market expansion. Market players are recommended to focus on innovation in drug formulation and delivery mechanisms, enhancing patient comfort and adherence. Cross-industry collaborations, especially with digital health companies, can amplify value propositions. Limitations include the high cost of advanced devices, potential side effects, and reimbursement issues, stressing the importance of market education and stakeholder engagement. Key areas ripe for research include personalized medicine approaches and the development of eco-friendly inhalers amidst rising environmental concerns over inhaler-generated greenhouse gases. Furthermore, continuous market insights are vital for adapting to evolving patient needs and regulatory frameworks. By addressing these factors, industry stakeholders can strategically position themselves within a dynamic market landscape, capitalizing on technological trends and unmet clinical needs to foster sustainable growth and development.

Understanding Market Dynamics in the Respiratory Inhalers Market

The Respiratory Inhalers Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rise in air pollution rate worldwide and occurrence of respiratory disorders
- Increasing consumer awareness of pulmonary disorders
- Growing government focus on improving asthma care
Market Restraints
- Stringent regulations for inhaler approvals by the government
Market Opportunities
- Introduction of innovative smart inhalers
- Development of effective inhaler medication formulations
Market Challenges
- Incorrect usage and operational issues in inhalers

Exploring Porter’s Five Forces for the Respiratory Inhalers Market

Porter’s Five Forces framework further strengthens the insights of the Respiratory Inhalers Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Respiratory Inhalers Market

External macro-environmental factors deeply influence the performance of the Respiratory Inhalers Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Respiratory Inhalers Market

The Respiratory Inhalers Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Respiratory Inhalers Market

The Respiratory Inhalers Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Respiratory Inhalers Market

The Respiratory Inhalers Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Inhalers Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Dry Powder Inhaler
- Metered Dose Inhaler
- Nebulizer
- Soft Mist Inhalers
Age Group
- Adults
- Pediatric
Mode
- Digitally Operated Devices
- Manually Operated Devices
Disease Indication
- Asthma
- Chronic Obstructive Pulmonary Disease
- Pulmonary Arterial Hypertension
End-Use
- Clinics & Hospitals
- Pharmacies
- Respiratory Care Center

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
5.1.1.2. Increasing consumer awareness of pulmonary disorders
5.1.1.3. Growing government focus on improving asthma care
5.1.2. Restraints
5.1.2.1. Stringent regulations for inhaler approvals by the government
5.1.3. Opportunities
5.1.3.1. Introduction of innovative smart inhalers
5.1.3.2. Development of effective inhaler medication formulations
5.1.4. Challenges
5.1.4.1. Incorrect usage and operational issues in inhalers
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Respiratory Inhalers Market, by Product Type

6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered Dose Inhaler
6.4. Nebulizer
6.5. Soft Mist Inhalers

7. Respiratory Inhalers Market, by Age Group

7.1. Introduction
7.2. Adults
7.3. Pediatric

8. Respiratory Inhalers Market, by Mode

8.1. Introduction
8.2. Digitally Operated Devices
8.3. Manually Operated Devices

9. Respiratory Inhalers Market, by Disease Indication

9.1. Introduction
9.2. Asthma
9.3. Chronic Obstructive Pulmonary Disease
9.4. Pulmonary Arterial Hypertension

10. Respiratory Inhalers Market, by End-Use

10.1. Introduction
10.2. Clinics & Hospitals
10.3. Pharmacies
10.4. Respiratory Care Center

11. Americas Respiratory Inhalers Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Respiratory Inhalers Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Respiratory Inhalers Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY INHALERS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. RESPIRATORY INHALERS MARKET DYNAMICS
TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. CANADA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 45. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 71. CHINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 72. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. INDIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 77. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. ITALY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 163. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 182. POLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 183. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. QATAR RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 188. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 235. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Respiratory Inhalers market, which are profiled in this report, include:

AstraZeneca PLC
Beximco Pharmaceuticals Ltd.
C.H. Boehringer Sohn Ko. KG
Cadila Healthcare Ltd.
Chiesi Farmaceutici S.p.A.
Cipla Limited
GlaxoSmithKline PLC
Heltman Medikal A.S.
Koninklijke Philips N.V.
Lupin Limited
Merck & Co., Inc.
Microlife Corporation
Novartis AG
Opko Health, Inc.
Rossmax International Ltd.
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.24 Billion
Forecasted Market Value ( USD ) by 2030	$ 5.68 Billion
Compound Annual Growth Rate	9.7%
Regions Covered	Global
No. of Companies Mentioned	17

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3487EUR$3,545USD£2,891GBP €3874EUR$3,939USD£3,212GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6169EUR$6,272USD£5,115GBP €6854EUR$6,969USD£5,683GBP

Understanding Market Dynamics in the Respiratory Inhalers Market

Exploring Porter’s Five Forces for the Respiratory Inhalers Market

Applying PESTLE Analysis to the Respiratory Inhalers Market

Analyzing Market Share in the Respiratory Inhalers Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Respiratory Inhalers Market

Strategic Recommendations for Success in the Respiratory Inhalers Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Digital Dose Inhaler Market by Type of Inhaler, Application, End-user, Component, Delivery Route, Prescription Type, Patient Age Group, Product Feature, Technology, Mode of Operation - Global Forecast 2025-2030

Inhalers & Nebulizers Market by Product, Indication, Distribution Mode - Global Forecast 2025-2030

Respiratory Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Smart Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030